Skip to main content

VAXCHORA (Biocelect Pty Ltd)

Product name
VAXCHORA
Date registered
Evaluation commenced
Decision date
Approval time
209 (255 working days)
Active ingredients
Vibrio cholerae
Registration type
NCE/NBE
Indication

VAXCHORA vaccine is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older travelling to cholera-affected countries.

VAXCHORA vaccine should be used in accordance with official recommendations.

The vaccine should not replace standard preventive hygiene measures.

Help us improve the Therapeutic Goods Administration site